Literature DB >> 32980940

A matched propensity score study of embryo morphokinetics following gonadotropin-releasing hormone agonist versus human chorionic gonadotropin trigger.

Galia Oron1,2, Onit Sapir3,4, Avital Wertheimer3,4, Yoel Shufaro3,4, Roni Bar-Gil3,4, Tamar Margalit3,4, Ekaterina Shlush3,4, Avi Ben-Haroush3,4.   

Abstract

PURPOSE: To compare morphokinetic parameters and quality of embryos derived from GnRH antagonist ICSI cycles triggered either with GnRH agonist or standard hCG between matched groups of patients.
METHODS: Morphokinetic parameters of embryos derived from matched first GnRH antagonist ICSI cycles triggered by GnRH agonist or standard hCG between 2013 and 2016 were compared. Matching was performed for maternal age, peak estradiol levels, and number of oocytes retrieved. Outcome measures were: time to pronucleus fading (tPNf), cleavage timings (t2-t8), synchrony of the second and third cycles (S2 and S3), duration of the second and third cycle (CC2 and CC3), optimal cell cycle division parameters, and known implantation data (KID) scoring for embryo quality. Multivariate linear and logistic regression analyses were performed for confounding factors.
RESULTS: We analyzed 824 embryos from 84 GnRH agonist trigger cycles and 746 embryos from 84 matched hCG trigger cycles. Embryos derived from the cycles triggered with hCG triggering cleaved faster than those deriving from GnRH agonist trigger. The differences were significant throughout most stages of embryo development (t3-t6), and a shorter second cell cycle duration of the hCG trigger embryos was observed. There was no difference in synchrony of the second and third cell cycles and the optimal cell cycle division parameters between the two groups, but there was a higher percentage of embryos without multinucleation in the hCG trigger group (27.8% vs. 21.6%, p < 0.001).
CONCLUSION: The type of trigger in matched antagonist ICSI cycles was found to affect early embryo cleavage times but not embryo quality.

Entities:  

Keywords:  GnRH agonist trigger; Morphokinetic parameters; Time lapse

Mesh:

Substances:

Year:  2020        PMID: 32980940      PMCID: PMC7642003          DOI: 10.1007/s10815-020-01953-w

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  26 in total

1.  Cleavage anomalies in early human embryos and survival after prolonged culture in-vitro.

Authors:  M Alikani; G Calderon; G Tomkin; J Garrisi; M Kokot; J Cohen
Journal:  Hum Reprod       Date:  2000-12       Impact factor: 6.918

2.  Use of gonadotropin-releasing hormone agonist to trigger follicular maturation for in vitro fertilization.

Authors:  Y Gonen; H Balakier; W Powell; R F Casper
Journal:  J Clin Endocrinol Metab       Date:  1990-10       Impact factor: 5.958

3.  No room for cancellation, coasting, or ovarian hyperstimulation syndrome in oocyte donation cycles.

Authors:  Eleuterio R Hernández; José Luis Gómez-Palomares; Elisabetta Ricciarelli
Journal:  Fertil Steril       Date:  2008-06-13       Impact factor: 7.329

Review 4.  GnRH agonist for triggering of final oocyte maturation: time for a change of practice?

Authors:  P Humaidan; S Kol; E G Papanikolaou
Journal:  Hum Reprod Update       Date:  2011-03-30       Impact factor: 15.610

5.  Is the retrieval of high numbers of oocytes desirable in patients treated with gonadotrophin-releasing hormone analogues (GnRHa) and gonadotrophins?

Authors:  A Pellicer; A Ruiz; R M Castellvi; C Calatayud; M Ruiz; J J Tarin; F Miró; F Bonilla-Musoles
Journal:  Hum Reprod       Date:  1989-07       Impact factor: 6.918

6.  LH (as HCG) and FSH surges for final oocyte maturation: sometimes it takes two to tango?

Authors:  Shahar Kol; Peter Humaidan
Journal:  Reprod Biomed Online       Date:  2010-06-27       Impact factor: 3.828

Review 7.  Can we eliminate severe ovarian hyperstimulation syndrome?

Authors:  Raoul Orvieto
Journal:  Hum Reprod       Date:  2004-11-26       Impact factor: 6.918

8.  Use of a single bolus of GnRH agonist triptorelin to trigger ovulation after GnRH antagonist ganirelix treatment in women undergoing ovarian stimulation for assisted reproduction, with special reference to the prevention of ovarian hyperstimulation syndrome: preliminary report: short communication.

Authors:  J Itskovitz-Eldor; S Kol; B Mannaerts
Journal:  Hum Reprod       Date:  2000-09       Impact factor: 6.918

9.  GnRH agonist triggering affects the kinetics of embryo development: a comparative study.

Authors:  Ali Sami Gurbuz; Funda Gode; Mehmet Sukru Uzman; Betul Ince; Melek Kaya; Necati Ozcimen; Emel Ebru Ozcimen; Ali Acar
Journal:  J Ovarian Res       Date:  2016-04-08       Impact factor: 4.234

Review 10.  GnRH agonist trigger versus hCG trigger in GnRH antagonist in IVF/ICSI cycles: A review article.

Authors:  Ashraf Alyasin; Shayesteh Mehdinejadiani; Marzieh Ghasemi
Journal:  Int J Reprod Biomed (Yazd)       Date:  2016-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.